Cannabis Law Report

APRIL 14, 2022

Read on to explore seven common environmental impacts affecting cannabis cultivators and processors, as well as opportunities to effectively manage those impacts, and join us for our upcoming webinar to learn more. Pesticide Misuse. Next Steps.

Environment 52

Environment Agriculture Compliance Compliance 52

Greenspoon Marder Cannabis Law Group Blog

JULY 18, 2019

In New Jersey, there are nearly 50,000 registered medical marijuana patients and only six Alternative Treatment Centers (ATCs) currently operating. Ability to provide appropriate research data. Interested parties may submit questions for regulators in advance of the NJ Department of Health webinar on August 2.If Criterion 5.

Law 40

Law Marijuana Education Safety 40

Cannabis Law Report

JULY 20, 2019

In New Jersey, there are nearly 50,000 registered medical marijuana patients and only six Alternative Treatment Centers (ATCs) currently operating. Ability to provide appropriate research data. Interested parties may submit questions for regulators in advance of the NJ Department of Health webinar on August 2.If Criterion 5.

Law 40

Law Marijuana Education Cultivation 40

The Cannigma

MARCH 25, 2021

It is also crucial so that the correct data is collected in order to inform further research and clinical trials that are necessary for cannabis medicines to reach the UK National Health Service. One of the ways we are achieving this is through our MDT webinar series. Showcasing medical cannabis in a real world setting.

Patients 145

Patients Clinical Trials Medicine Events 145

Canna Law Blog

JULY 25, 2022

It is inevitable that marijuana legalization sweeps the globe–if you haven’t seen it yet, please watch our webinar with Clifford Chance about the existing global economy of marijuana. Exciting developments lie ahead for European Union (EU) marijuana legalization. The question is just one of timing. In the U.S.,

Legalization 91

Legalization Marijuana Safety Policy 91

The Cannigma

NOVEMBER 23, 2021

Listen & Subscribe: Finding the correct dosage and combination of cannabinoid products for medical treatment is almost universally a long and expensive process of trial and error. The app helps patients make sense of their journey by simplifying the information and supplying data-driven insights into their regimen and its effects.

Data 52

Data Patients Access Wellness and Beauty 52

Healer

JANUARY 17, 2022

While THC’s maximal pain reduction was better (THC had the potential for stronger relief at much higher doses), this data suggests CBG could be a cost-effective agent for pain, effective at low doses without the impairment possibility related to THC. That’s a significant reduction that could be important in the treatment for glaucoma.

Cannabinoids 52

Cannabinoids Nerve Pain Research and Development THC 52